Eurasian Harm Reduction Association (EHRA) is a non-for-profit public membership-based organisation, registered by the initiative of harm reduction activists and organisations from Central and Eastern Europe and Central Asia (CEECA) in 2017.

We strive for a progressive human rights-based drug policy, sustainable funding advocacy and quality of harm reduction services oriented on needs of people who use drugs.

SUB-REGIONS

Baltics, Central Europe, South-Eastern Europe, European Countries of the Commonwealth of Independent States, Caucasus, Russia, Central Asia

COUNTRIES

Albania, Armenia, Azerbaijan, Belarus, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Hungary, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan

 MEMBERS

Association is a membership based network. Nowadays the Association includes 202 members from CEECA region

Pilot OST Programs in Kazakhstan – How to Avoid Being Thrown Overboard
Author: Dasha Matyushina, Drug Policy and Human Rights Advisor, EHRA In my almost twenty years of working in harm reduction I have visited many opioid substitution therapy sites in different countries. One of the first programs I was lucky to see was an OST site in New York. A likeable
Read more.
Community, Rights & Gender Technical Assistance Program
The Community, Rights and Gender (CRG) Technical Assistance Program provides support to civil society and community organizations to meaningfully engage in the Global Fund model, including during: Country dialogue Funding request development Grant-making Grant implementation Under this program, national civil society and community organizations can apply for technical assistance in
Read more.
Sustainability and integration of HIV and TB services for vulnerable people in Europe is in focus
Author: Yuliia Holub In 2014, WHO diagnosed in European region 80% more new HIV cases than ten years earlier. The Eastern part of the region has the fastest growing HIV data and the second lowest treatment access in the world. As well as the highest rates of the global multidrug-resistant
Read more.